Global Drug Development

BMS employee, Ajlan Atasoy, MD

Learn Why Two Science Leaders Who Left BMS Were Inspired to Return

Building Careers /

Delivering groundbreaking treatments and doing transformative work. That’s what motivated two scientists who had worked for BMS to return after pursuing opportunities outside of the organization. Hear what motivated Ajlan Atasoy, MD, Clinical Development Lead, Senior Director, Oncology, and Glenda Trujillo, PhD, Senior Director, Worldwide Medical Immunology and Neuroscience, Pulmonary Fibrosis, to make the return trip to BMS, and continue to do the most interesting, meaningful work of their careers. Inspired by the Innovation and Enthusiasm at BMS For Glenda, earning a PhD in molecular and cell biology was the start of what has become a career devoted to researching hard-to-treat illnesses. Having worked in pathology labs as well as […]

Learn Why Two Science Leaders Who Left BMS Were Inspired to Return Read More »

Delivering groundbreaking treatments and doing transformative work. That’s what motivated two scientists who had worked for BMS to return after pursuing opportunities outside of the organization. Hear what motivated Ajlan Atasoy, MD, Clinical Development Lead, Senior Director, Oncology, and Glenda Trujillo, PhD, Senior Director, Worldwide Medical Immunology and Neuroscience, Pulmonary Fibrosis, to make the return trip to BMS, and continue to do the most interesting, meaningful work of their careers. Inspired by the Innovation and Enthusiasm at BMS For Glenda, earning a PhD in molecular and cell biology was the start of what has become a career devoted to researching hard-to-treat illnesses. Having worked in pathology labs as well as

BMS employees working in a lab in Boudry, Switzerland.

BMS Boudry: Drug Development Opportunity in a Culturally Diverse Hub

Building Careers /

Opportunity to grow as leaders. Breakthrough science that addresses unmet medical needs. Talented colleagues in a multicultural environment. Diversity of thought and perspective. These powerful forces are what drew two senior leaders to BMS Boudry. Hear why Matthew Klimek, Vice President, Global Program Lead, Hematology, and Nikolay Delev, MD, Clinical Development Program Lead, Rheumatology, relocated from the U.S. to Switzerland and are happy to call BMS Boudry home. At the Intersection of Professional and Personal Opportunity For Matthew, the decision to relocate to Boudry, Switzerland was twofold. First, it presented the opportunity to combine his experience in commercialization and regulatory affairs in a role that oversees a lymphoma asset in

BMS Boudry: Drug Development Opportunity in a Culturally Diverse Hub Read More »

Opportunity to grow as leaders. Breakthrough science that addresses unmet medical needs. Talented colleagues in a multicultural environment. Diversity of thought and perspective. These powerful forces are what drew two senior leaders to BMS Boudry. Hear why Matthew Klimek, Vice President, Global Program Lead, Hematology, and Nikolay Delev, MD, Clinical Development Program Lead, Rheumatology, relocated from the U.S. to Switzerland and are happy to call BMS Boudry home. At the Intersection of Professional and Personal Opportunity For Matthew, the decision to relocate to Boudry, Switzerland was twofold. First, it presented the opportunity to combine his experience in commercialization and regulatory affairs in a role that oversees a lymphoma asset in

BMS Drug Development leader, Nataraj Kalyanaraman, in a dark blazer and wearing glasses

A Leader’s Career Journey Comes Full Circle to Drug Development in BMS Hyderabad

Building Careers /

At BMS, our people directly reflect the strength of our global footprint. Such is the case for Nataraj Kalyanaraman, who joined BMS in 2017. Nataraj began his BMS journey in the U.S., working on the Research and Development (R&D) strategy team in New Jersey. In 2022 he relocated to Lausanne, Switzerland to expand our drug development capabilities. Not only did he achieve this goal, Nataraj grew the organization, setting a strong foundation for drug development in Europe. Now, Nataraj has come full circle to his homeland of India as Vice President, Head of BMS Hyderabad for Global Drug Development. In July 2023, he opened the doors to Drug Development at

A Leader’s Career Journey Comes Full Circle to Drug Development in BMS Hyderabad Read More »

At BMS, our people directly reflect the strength of our global footprint. Such is the case for Nataraj Kalyanaraman, who joined BMS in 2017. Nataraj began his BMS journey in the U.S., working on the Research and Development (R&D) strategy team in New Jersey. In 2022 he relocated to Lausanne, Switzerland to expand our drug development capabilities. Not only did he achieve this goal, Nataraj grew the organization, setting a strong foundation for drug development in Europe. Now, Nataraj has come full circle to his homeland of India as Vice President, Head of BMS Hyderabad for Global Drug Development. In July 2023, he opened the doors to Drug Development at

Clinical Trial

Leading with Inclusion: Two Careers Driving Diversity in Clinical Trials

Global Inclusion & Diversity /

Senior clinical scientist Jessica Brescher and senior engagement strategy lead Erika Heiges are on the forefront of increasing diversity within clinical trial populations, while simultaneously guiding their own career growth through critical work at Bristol Myers Squibb (BMS). Their fascinating journeys are reflective of many of our BMS colleagues with diverse education and experience who have translated their passions and learning objectives into interesting and meaningful careers. “In conducting clinical research, we cannot be exclusive or biased to one particular patient population,” said Erika. “We need to make sure that all patient communities participate in our studies so that science and research reflects the epidemiology of the disease being studied.”

Leading with Inclusion: Two Careers Driving Diversity in Clinical Trials Read More »

Senior clinical scientist Jessica Brescher and senior engagement strategy lead Erika Heiges are on the forefront of increasing diversity within clinical trial populations, while simultaneously guiding their own career growth through critical work at Bristol Myers Squibb (BMS). Their fascinating journeys are reflective of many of our BMS colleagues with diverse education and experience who have translated their passions and learning objectives into interesting and meaningful careers. “In conducting clinical research, we cannot be exclusive or biased to one particular patient population,” said Erika. “We need to make sure that all patient communities participate in our studies so that science and research reflects the epidemiology of the disease being studied.”

Biostats in Boudry

Exciting Careers in Biostatistics and Trial Management at BMS Boudry

Meet Our People /

Overlooking Lake Neuchâtel at the foot of the Swiss Alps, lies the city of Boudry, a picture-perfect location that attracts a diverse workforce from around the world. Some, like the 1,000 or so Bristol Myers Squibb employees, come to Boudry to do some of the most meaningful work of their careers, and in a variety of critical roles. Romain Piault, Senior Manager, Biostatistics, and Marina Arias Parro, Senior Global Trial Manager, are among just two of the more than 50 nationalities at BMS Boudry. Both are key members of BMS’s Global Drug Development organization which oversees several important stages of the drug life cycle, including regulatory, biostatistics, operations and clinical

Exciting Careers in Biostatistics and Trial Management at BMS Boudry Read More »

Overlooking Lake Neuchâtel at the foot of the Swiss Alps, lies the city of Boudry, a picture-perfect location that attracts a diverse workforce from around the world. Some, like the 1,000 or so Bristol Myers Squibb employees, come to Boudry to do some of the most meaningful work of their careers, and in a variety of critical roles. Romain Piault, Senior Manager, Biostatistics, and Marina Arias Parro, Senior Global Trial Manager, are among just two of the more than 50 nationalities at BMS Boudry. Both are key members of BMS’s Global Drug Development organization which oversees several important stages of the drug life cycle, including regulatory, biostatistics, operations and clinical